Oral treatment with RU 41.740 (BiostimTM) in patients with advanced colorectal cancer: Influence on the blood lymphocyte population
- 31 December 1989
- journal article
- case report
- Published by Elsevier BV in International Journal of Immunopharmacology
- Vol. 11 (1), 71-76
- https://doi.org/10.1016/0192-0561(89)90101-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The effect of RU 41.740 (Biostim) on the production of interleukin-1 by monocytes and enriched large granular lymphocytes in normals and patients with hepatocellular carcinomaCancer Immunology, Immunotherapy, 1986
- Immunoglobulin M and immunoglobulin G secretion by human B cells exposed to RU 41.740, a glycoprotein extract from Klebsiella pneumoniaeCellular Immunology, 1985
- Induction of interleukin 1 secretion by murine macrophages and human monocytes after stimulation by RU 41740, a bacterial immunomodulatorInternational Journal of Immunopharmacology, 1985
- Immunological activities of RU-41740, a glycoproteic extract from klebsiella pneumoniaeAnnales de l'Institut Pasteur / Immunologie, 1984
- Conversion of skin tests in cancer patients after a short course of treatment with a new immunostimulating compoundCancer Immunology, Immunotherapy, 1980
- Characteristics of human mononuclear phagocytesBlood, 1979
- Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferonInternational Journal of Cancer, 1978